Charytoniuk T - Search Results

1

Distinct Effects of Cannabidiol on Sphingolipid Metabolism in Subcutaneous and Visceral Adipose Tissues Derived from High-Fat-Diet-Fed Male Wistar Rats.

Berk K, Konstantynowicz-Nowicka K, Charytoniuk T, Harasim-Symbor E, Chabowski A. Berk K, et al. Among authors: charytoniuk t. Int J Mol Sci. 2022 May 11;23(10):5382. doi: 10.3390/ijms23105382. Int J Mol Sci. 2022. PMID: 35628194 Free PMC article.

2

The Endocannabinoid System and Physical Activity-A Robust Duo in the Novel Therapeutic Approach against Metabolic Disorders.

Charytoniuk T, Zywno H, Berk K, Bzdega W, Kolakowski A, Chabowski A, Konstantynowicz-Nowicka K. Charytoniuk T, et al. Int J Mol Sci. 2022 Mar 12;23(6):3083. doi: 10.3390/ijms23063083. Int J Mol Sci. 2022. PMID: 35328503 Free PMC article. Review.

3

Cannabidiol Downregulates Myocardial de Novo Ceramide Synthesis Pathway in a Rat Model of High-Fat Diet-Induced Obesity.

Charytoniuk T, Sztolsztener K, Bielawiec P, Chabowski A, Konstantynowicz-Nowicka K, Harasim-Symbor E. Charytoniuk T, et al. Int J Mol Sci. 2022 Feb 17;23(4):2232. doi: 10.3390/ijms23042232. Int J Mol Sci. 2022. PMID: 35216351 Free PMC article.

4

Cannabidiol - A phytocannabinoid that widely affects sphingolipid metabolism under conditions of brain insulin resistance.

Charytoniuk T, Sztolsztener K, Harasim-Symbor E, Berk K, Chabowski A, Konstantynowicz-Nowicka K. Charytoniuk T, et al. Biomed Pharmacother. 2021 Oct;142:112057. doi: 10.1016/j.biopha.2021.112057. Epub 2021 Aug 19. Biomed Pharmacother. 2021. PMID: 34435590 Free article.

5

Phytocannabinoids-A Green Approach toward Non-Alcoholic Fatty Liver Disease Treatment.

Berk K, Bzdega W, Konstantynowicz-Nowicka K, Charytoniuk T, Zywno H, Chabowski A. Berk K, et al. Among authors: charytoniuk t. J Clin Med. 2021 Jan 20;10(3):393. doi: 10.3390/jcm10030393. J Clin Med. 2021. PMID: 33498537 Free PMC article. Review.

6

Can Physical Activity Support the Endocannabinoid System in the Preventive and Therapeutic Approach to Neurological Disorders?

Charytoniuk T, Zywno H, Konstantynowicz-Nowicka K, Berk K, Bzdega W, Chabowski A. Charytoniuk T, et al. Int J Mol Sci. 2020 Jun 13;21(12):4221. doi: 10.3390/ijms21124221. Int J Mol Sci. 2020. PMID: 32545780 Free PMC article. Review.

7

The effect of enterolactone on liver lipid precursors of inflammation.

Berk K, Drygalski K, Harasim-Symbor E, Charytoniuk T, Iłowska N, Łukaszuk B, Chabowski A, Konstantynowicz-Nowicka K. Berk K, et al. Among authors: charytoniuk t. Life Sci. 2019 Mar 15;221:341-347. doi: 10.1016/j.lfs.2019.02.044. Epub 2019 Feb 22. Life Sci. 2019. PMID: 30802511

8

Influence of Resveratrol on Sphingolipid Metabolism in Hepatocellular Carcinoma Cells in Lipid Overload State.

Charytoniuk T, Harasim-Symbor E, Polak A, Drygalski K, Berk K, Chabowski A, Konstantynowicz-Nowicka K. Charytoniuk T, et al. Anticancer Agents Med Chem. 2019;19(1):121-129. doi: 10.2174/1871520619666181224161255. Anticancer Agents Med Chem. 2019. PMID: 30585550

9

The effect of enterolactone on sphingolipid pathway and hepatic insulin resistance development in HepG2 cells.

Charytoniuk T, Iłowska N, Berk K, Drygalski K, Chabowski A, Konstantynowicz-Nowicka K. Charytoniuk T, et al. Life Sci. 2019 Jan 15;217:1-7. doi: 10.1016/j.lfs.2018.11.044. Epub 2018 Nov 20. Life Sci. 2019. PMID: 30468835

10

Progression to chronic kidney disease in patients undergoing nephrectomy for small renal masses: a price to pay for a therapeutic success?

Charytoniuk T, Małyszko M, Bączek J, Fiedorczuk P, Siedlaczek K, Małyszko J. Charytoniuk T, et al. Postgrad Med. 2018 Sep;130(7):613-620. doi: 10.1080/00325481.2018.1511211. Epub 2018 Aug 27. Postgrad Med. 2018. PMID: 30106608 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results